Abstracts have to be submitted electronically through the conference website via an online form (http://whocc.goeg.at/Conference2015/AbstractSubmission). The receipt of your abstract will be confirmed by an automatically generated e-mail indicating the reference number of your abstract. Please include this reference number in all your communications relating to the abstract submission.
Abstract submission was closed on 28 May 2015
You will be informed by mid-July 2015 if your abstract was accepted and in which form it can be presented (oral presentation, brief poster presentation, poster without presentation; see further details below).
If your abstract is accepted, there are three possibilities of presenting your work:
Authors of the highest rated submissions per strand will be invited to present their work during a presentation of maximum 10 minutes, followed by a brief question & answer session.
For each of the three strands, five abstracts will be selected for an oral presentation.
Presenters will qualify for a reduced conference fee.
Please note that the best presentation will be selected and recognized at the conference.
Authors of high rated submissions will be invited to present their work during a brief oral presentation of their poster (no slides). The presentation should be limited to 5 minutes and will be followed by a brief question & answer session (max. 5 minutes).
Four poster submissions per strand will be selected.
In addition, further accepted submissions will be granted the possibility to be displayed as a poster (no presentation).
Please note that the best poster will be recognized with an award during the conference.
A selection of abstracts will be published in the Conference Proceedings Supplement of the BioMed Central Journal of Pharmaceutical Policy and Practice (JOPPP). Please indicate your consent for your abstract to be published during abstract submission.
Submitted abstracts are evaluated by the members of the Scientific Programme Committee (http://whocc.goeg.at/Conference2015/ProgrammeCommittee) or further experts nominated by the Committee.
Topics that are likely to be highly ranked for conference presentation include:
(1) an impact assessment/evaluation of a pharmaceutical pricing and/or reimbursement policy implemented in response to and/or during the global financial crisis;
(2) an assessment of cross-country cooperation initiative (e.g. joint procurement, sharing of information);
(3) an evaluation of an ‘interface management initiative’, i.e. a project to better manage medicines between the in- and out-patient sectors via defined organisation/supply models or funding schemes (e.g. joint reimbursement list, joint/specific committee);
The abstract text must not exceed 400 words. These 400 words do not include title, authors, keywords and funding sources.
Submissions should relate to completed or ongoing research (with preliminary results) and must be in English.
Conference strand in which the abstract is submitted (for selection):
Strand 1 – Challenges and Opportunities for Pricing and Reimbursement Policies
Strand 2 – Policy Responses to the Financial Crisis: Lessons Learned
Strand 3 – Policy Cooperation and Interface Issues
Title of the abstract: Please enter a short title of your abstract
Authors: Names of Authors and Authors's affiliations (full contact details) should be listed.
Age of presenting (Co-) Author: Please provide the birth year of the presenting author if you wish to be considered for the young researcher award. (All authors below the age of 35 will be considered.)
Lesson(s) learned and success factor(s) – optional, but recommended: State here relevant factors of the success of the policy and intervention surveyed or barriers from which others could learn.
Keywords: Choose up to five keywords that best describe your survey, analysis or evaluation. You are invited to select from the examples given in the previous section Issues for abstract submission, but you are also welcome to indicate further keywords.
Funding Source(s): Name the organization(s) that funded / are funding the research.
(If consenting to be published in the JOPPP supplement, please upload an abstract in the specified format)